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InthispatientwithMarfan’ssyndromeandischae-
mic stroke thrombolysis was associated with good
outcome in spite of haemorrhagic transformation.
Introduction
Marfan syndrome is an autosomal dominant
inherited disorder of the connective tissue with
pleiotropic manifestations in the classic triad of
ocular, skeletal, and cardiovascular systems.
Characteristic clinical features include a thin tall
stature, pectus carinatum or excavatum, scoliosis,
joint hypermobility, arachnodactyly, pes planus,
a high arched palate, and ectopia lentis.
1 The syn-
drome has an incidence of around 1 in 9800.
2
Weakness of the blood vessels, especially the
aorta, causes progressive dilatation of the aortic
root leading to aortic regurgitation, dissection, or
rupture, which is the most common life threaten-
ing feature of the Marfan syndrome.
1 Neurovascu-
lar complications of Marfan syndrome are rare,
and mostly ischaemic in nature.
3 An association
between Marfan syndrome and intracranial aneur-
ysms has been described in one autopsy series of 7
cases in 1997,
1 but was not conﬁrmed in larger
autopsy series of 25 Marfan cases.
1 Thrombolysis
is now a standard treatment for acute ischaemic
stroke. We found no report of thrombolytic treat-
ment for acute ischaemic stroke in patients with
Marfan syndrome in the literature.
Case report
A 57-year-old man with known Marfan syndrome
was admitted to the emergency department with
sudden onset of right arm and leg weakness and
slurred speech 50 min before presentation. His
past medical history included a metallic aortic
valve replacement 12 years ago, which was
infected with MRSA and so this was replaced
with tissue valve a month later. Other history
included mild congestive heart failure
(New York Heart Association class II) and a transi-
ent ischemic attack 2 years ago. Echocardiography
(ECHO) 1 year prior to this admission had shown
an ejection fraction of 41% but stable prosthetic
valves. He was ﬁt and independent in activities
of daily living. His medications on admission
were frusemide, bisoprolol, amlodipine, losartan,
spironolactone, and ﬂuoxetine. He was no longer
taking aspirin and dipyridamole at the time of
admission.
On examination, he had a partial left anterior
circulation syndrome with right hemiparesis
(Medical Research Council grade power of 3/5i n
the arm and 4/5 in the leg), a right upper motor
neuron facial palsy, expressive dysphasia, and
right sided visual neglect. His National Institute
of Health Stroke Scale (NIHSS) score was 12. His
blood pressure was low at 100/80 mm Hg. Apart
from the thoracotomy scar, and the tall features
of Marfan syndrome his physical examination
was normal. Routine blood tests, electrocardio-
gram and chest X-ray were normal. A computed
tomogram (CT) of the head, performed 2 h after
symptom onset, did not show evidence of infarc-
tion or haemorrhage (Figure 1). Intravenous
thrombolysis with alteplase at a dose of 0.9 mg/kg
bodyweight was started 2 hours and 30 min after
the onset of symptoms. There were no immediate
complications, and he remained haemodynami-
cally stable. Twenty hours later he became
drowsy. His NIHSS score worsened to 18 with
more pronounced right hemiparesis. A repeat CT
head scan (Figure 2) showed an established left
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1middle cerebral artery territory infarct with hae-
morrhagic transformation within the infarcted
area. There was also swelling of the ipsilateral left
cerebral hemisphere with mild midline shift
towards right. Over the next few days, the patient
gradually improved with continued physiotherapy.
At 9 days, he was able to transfer independently
from bed to chair. His NIHSS score was 7 with
word ﬁnding problems, partial right hemianopia,
right visual neglect and a mild right hemiparesis.
A Repeat CT head scan at 2 weeks showed an
established infarct and complete resolution of hae-
morrhagic transformation (Figure 3). At this stage
hewas commenced on aspirin. Hewas discharged
home after 3 weeks when he was mobilizing inde-
pendently, though he had mild right upper limb
weakness, dysphasia and cognitive impairment.
At three months he was able to communicate
and physically independent, but he was unable
to return to his usual hobbies and work because
his memory had deteriorated, he could not coordi-
nate his right hand, and had word ﬁnding
problems. He underwent further investigations
to discover the aetiology of the stroke. Carotid
Doppler did not show any evidence of signiﬁcant
carotid stenosis. ECHO cardiography showed a
normal aortic root and a normally functioning
prosthetic aortic valve though the ejection fraction
was low at 41%. There was no evidence of aortic
dissection.
Discussion
To our knowledge, this is the ﬁrst report of a
patient with Marfan syndrome treated with
thrombolysis for acute ischaemic stroke. In our
patient, thrombolysis was complicated by haem-
orrhage into the infarcted brain. This resulted in
transient deterioration of his neurological status,
but overall recovery was good, considering the
extent of the infarction. There was no evidence of
an underlying vascular malformation, and the
pattern of the haemorrhage suggested widespread
haemorrhagic transformation rather than a bleed
Figure 2
CT head scan 20 hours post thrombolysis
showing left middle cerebral artery territory
infarct with haemorrhagic transformation within
the infarcted area
Figure 1
CT head scan before thrombolysis showing no
evidence of established infarct or haemorrhage
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2from an abnormal vessel. It is therefore unlikely
that his haemorrhage was due to Marfan-related
connective tissue disease. It is highly likely that
this patient’s stroke could be cardioembolic
because of poor left ventricular function and pros-
thetic valves. This is a risk factor for haemorrhagic
complications. While it is important to report this
ﬁnding, it would not be appropriate to withhold
thrombolysis from patients with Marfan syn-
drome in future on the basis of our report. It is
also important to rule out the possibility of aortic
dissection in Marfan patients before thrombolysis.
Although the pathophysiology of the disease
would make a predisposition to intracranial
aneurysms likely, there is no convincing evidence
for this from published reports. The incidence of
intracranial aneurysms in Marfan syndrome in
the two reported autopsy series is 2/7 in one
4
and 1 small out of 25 in the other.
5 Taking the
two studies together, there were two asympto-
matic haemorrhages (age 32 and age 30) and one
symptomatic fatal subarachnoid haemorrhage
(age 20) in 32 reported cases. This is not sufﬁcient
information to judge whether there is a signiﬁcant
difference from the population rate of 1.3%.
6
As in the patient reported here, cerebral ischae-
mic events are the most common neurovascular
complications of Marfan syndrome. In a retrospec-
tive case series of 513 patients with Marfan Syn-
drome, 3.5% had cerebrovascular events, 83% of
these were ischaemic (11 transient ischaemic
attacks, 2 cerebral infarcts, 2 spinal cord infarc-
tions) and 16% (3 patients) haemorrhagic (2 sub-
dural haematomas, and 1 spinal subarachnoid
haemorrhage). The mean age of affected patients
in this series was 39.6 years, considerably lower
than the average for strokes in the general popu-
lation. A high risk source of cardiac embolism
was identiﬁed in 77% (prosthetic cardiac valves,
atrial ﬁbrillation).
3
Current evidence suggests that Marfan patients
are at risk of cerebral ischaemic events at a young
age. The patient we report here, developed a
haemorrhagic complication after thrombolysis,
which did not affect his recovery. More reports
on thrombolysis outcome in Marfan patients
are required to assess its safety in this patient
group.
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Figure 3
CT head scan at 2 weeks showing established left
middle cerebral artery territory infarct as pre-
viously demonstrated. The haemorrhagic trans-
formation is longer visible
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